Muntlig fråga om flytten av Fimeas huvudort (Stefan Wallin sv)

This procedure is an oral question regarding the decision to move the headquarters of Fimea, the Finnish Medicines Agency. It addresses the reasoning behind the relocation and its potential impact on the pharmaceutical sector and regional development. The move primarily affects the pharmaceutical industry, healthcare administration, and the local economy of the regions involved in the relocation process.